Tissue, I hardly know you!: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
PLAN OF TASKS: | PLAN OF TASKS: | ||
<nowiki> | |||
--periostin part on registry | --periostin part on registry | ||
--research safety and security | --research safety and security | ||
| Line 15: | Line 16: | ||
--competition | --competition | ||
--costs (as part of 6 month plan) | --costs (as part of 6 month plan) | ||
--finalize collagenase part | --finalize collagenase part</nowiki> | ||
Devices: | Devices: | ||
Revision as of 12:50, 23 April 2008
20.20 Tissue Engineering Group
- Group members: Anna, Amber, Derek, Prarthna, Mike, Robbie, and Aditya
Use this space to communicate with each othhttp://openwetware.org/skins/common/images/button_extlink.pnger and to formulate your ideas. Here's a link to the technical specification review requirements([1]).
PLAN OF TASKS:
--periostin part on registry --research safety and security --bactoblood --antibodies on heart --binding --finalize pathways from binding to NAND gates --6 month plan --competition --costs (as part of 6 month plan) --finalize collagenase part
Devices:
- targeting mechanism (specific for heart scar tissue)
- propulsion device (might not be necessary if we just let the cells travel with blood flow)
- binding device
- scar-digesting device
- healthy heart cell regeneration device
- cell death / exit device
[useful articles that discuss proteins expressed in cardiac scar and healthy tissue and how the two tissues differ.]
[2]
[Periostin and Myocardial Repair, Regeneration, and Recovery [3]]
[Summary of research on targeting scar heart tissue as well as binding to healthy and scarred cardiac cells.
Also includes a summary of monoclonal antibody production
and a diagram of the cardiac extracellular matrix (useful for figuring out how our bacterium will bind to it).
]
== POWERPOINT FOR TECH SPEC REVIEW ==
TOPICS FOR ADDITIONAL RESEARCH:
1. Do we keep the bacteria in the heart until they die, or do we inject the patient with a drug to end the bacteria's life cycle.
- research the life span of the bacteria - how would the bacteria behave when they die? Do they automatically unbind from the cell or are external factors necessary.
2. Ways to prevent the immune system from responding to the bacteria
-could a coating be synthesized to prevent bacterial death and to prevent an immune system response.
3. Will Verapamil (the scar repressing agent) interact with periostin?
4. How quickly does cardiac tissue form?
- If it forms slowly relative to the speed at which periostin regenerates heart tissue, it is not necessary to include scar repressors.
DIAGRAMS
File:C:\Users\Anna Shcherbina\Pictures\DSCF2071.jpg File:C:\Users\Derek Ju\Pictures\collagenase.jpg
